Polyclonal dissemination of tetracycline resistance among streptococcus pyogenes paediatric isolates from Brazil

Journal of Infection in Developing Countries

Volumn 4, Issue 11, 2010, Pages 704-711

  Smeesters, Pierre Robert ^a,b   Cadar, Sabina ^b   Drèze, Pierre Alexandre ^a   Campos, Dioclécio Junior ^c   van Melderen, Laurence ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^c HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

Author keywords

Emm gene; GAS phylogeny; Minocycline resistance; Tetracycline resistance

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; MINOCYCLINE; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BRAZIL; CHILD; CHILD CARE; CLINICAL TRIAL; GROUP A STREPTOCOCCAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; STREPTOCOCCUS INFECTION; TETK GENE; TETL GENE; TETM GENE; TETO GENE;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 78650318620     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1138     Document Type: Article

References (47)

1. Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3: 191-200.
2. Smeesters PR, Dreze PA, Perez-Morga D, Biarent D, Van Melderen L, Vergison A (2010) Group A Streptococcus virulence and host factors in two toddlers with rheumatic fever following toxic shock syndrome. Int J Infect Dis 14: e403-409.
3. Bisno AL, Gerber MA, Gwaltney JM, Jr., Kaplan EL, Schwartz RH (2002) Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 35: 113-125.
4. Montagnani F, Stolzuoli L, Croci L, Rizzuti C, Arena F, Zanchi A, Cellesi C (2009) Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region. Infection 37: 353-357.
5. Freeman AF, Shulman ST (2002) Macrolide resistance in group A Streptococcus. Pediatr Infect Dis J 21: 1158-1160.
6. Robinson DA, Sutcliffe JA, Tewodros W, Manoharan A, Bessen DE (2006) Evolution and global dissemination of macrolide-resistant group A streptococci. Antimicrob Agents Chemother 50: 2903-2911.
7. Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis 41: 599-608.
8. Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR (2006) Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob Agents Chemother 50: 256-261.
9. Strakova L, Motlova J, Jakubu V, Urbaskova P, Kriz P (2007) Emergence of a novel macrolide-resistant Streptococcus pyogenes emm53 strain. Clin Microbiol Infect 13: 443-445.
10. De Melo MC, Sa Figueiredo AM, Ferreira-Carvalho BT (2003) Antimicrobial susceptibility patterns and genomic diversity in strains of Streptococcus pyogenes isolated in 1978-1997 in different Brazilian cities. J Med Microbiol 52: 251-258.
11. Teixeira LM, Barros RR, Castro AC, Peralta JM, Da Gloria SCM, Talkington DF, Vivoni AM, Facklam RR, Beall B (2001) Genetic and phenotypic features of Streptococcus pyogenes strains isolated in Brazil that harbor new emm sequences. J Clin Microbiol 39: 3290-3295.
12. D'Oliveira RE, Barros RR, Mendonca CR, Teixeira LM, Castro AC (2003) Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil. Microb Drug Resist 9: 87-91.
13. Mendes C, Marin ME, Quinones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, Lopez H, Sucari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D (2003) Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000). Braz J Infect Dis 7: 44-61.
14. Pereira FS, Bucaretchi F, Stephan C, Cordeiro R (2007) Self-medication in children and adolescents. J Pediatr (Rio J) 83: 453-458.
15. Volpato DE, de Souza BV, Dalla Rosa LG, Melo LH, Daudt CA, Deboni L (2005) Use of antibiotics without medical prescription. Braz J Infect Dis 9: 288-291.
16. Bergman M, Huikko S, Pihlajamaki M, Laippala P, Palva E, Huovinen P, Seppala H (2004) Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 38: 1251-1256.
17. Jasir A, Tanna A, Noorani A, Mirsalehian A, Efstratiou A, Schalen C (2000) High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. J Clin Microbiol 38: 2103-2107.
18. Malhotra-Kumar S, Lammens C, Chapelle S, Wijdooghe M, Piessens J, Van Herck K, Goossens H (2005) Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg Infect Dis 11: 939-942.
19. Shlaes DM (2006) An update on tetracyclines. Curr Opin Investig Drugs 7: 167-171.
20. Smeesters PR, McMillan DJ, Sriprakash KS (2010) The streptococcal M protein: a highly versatile molecule. Trends Microbiol 18: 275-282.
21. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
22. Smeesters PR, Vergison A, Campos D, de Aguiar E, Miendje Deyi VY, Van Melderen L (2006) Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape. PLoS ONE 1: e10.
23. Smeesters PR, Mardulyn P, Vergison A, Leplae R, Van Melderen L (2008) Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development. Vaccine 26: 5835-5842.
24. Smeesters PR, Vergison A, Junior DC, Van Melderen L (2009) Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations. Int J Antimicrob Agents 34: 44-49.
25. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
26. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evol 24: 1596-1599.
27. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
28. McGregor KF, Spratt BG, Kalia A, Bennett A, Bilek N, Beall B, Bessen DE (2004) Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol 186: 4285-4294.
29. Beall B, Gherardi G, Lovgren M, Facklam RR, Forwick BA, Tyrrell GJ (2000) Emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology 146 (Pt 5): 1195-1209.
30. Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstratiou A, Thompson TA, Gowan S, Kriz P, Tyrrell GJ, Kaplan E, Beall B (2002) Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis 34: 28-38.
31. Sakota V, Fry AM, Lietman TM, Facklam RR, Li Z, Beall B (2006) Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J Clin Microbiol 44: 2160-2166.
32. National Committee for Clinical Laboratory Standards (2002). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Twelfth Informational Supplement: Approved Standard M100-S12. (NCCLS, Wayne, PA, USA.).
33. Malhotra-Kumar S, Lammens C, Piessens J, Goossens H (2005) Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob Agents Chemother 49: 4798-4800.
34. Smeesters PR, Campos D, Jr., Van Melderen L, de Aguiar E, Vanderpas J, Vergison A (2006) Pharyngitis in low-resources settings: a pragmatic clinical approach to reduce unnecessary antibiotic use. Pediatrics 118: e1607-1611.
35. Smeesters PR, Dramaix M, Van Melderen L The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS. Vaccine 28: 883-885.
36. Bessen DE, Carapetis JR, Beall B, Katz R, Hibble M, Currie BJ, Collingridge T, Izzo MW, Scaramuzzino DA, Sriprakash KS (2000) Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J Infect Dis 182: 1109-1116.
37. Espinosa LE, Li Z, Gomez Barreto D, Calderon Jaimes E, Rodriguez RS, Sakota V, Facklam RR, Beall B (2003) M protein gene type distribution among group A streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000, and Durango, Mexico, from 1998 to 1999: overlap with type distribution within the United States. J Clin Microbiol 41: 373-378.
38. Cochetti I, Tili E, Mingoia M, Varaldo PE, Montanari MP (2008) Erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003. Antimicrob Agents Chemother 52: 1285-1290.
39. Rice LB (1998) Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob Agents Chemother 42: 1871-1877.
40. Ripa S, Zampaloni C, Vitali LA, Giovanetti E, Montanari MP, Prenna M, Varaldo PE (2001) SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes. Microb Drug Resist 7: 65-71.
41. Smeesters PR, McMillan DJ, Sriprakash KS, Georgousakis MM (2009) Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines? Expert Rev Vaccines 8: 1705-1720.
42. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE (2001) Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun 69: 2416-2427.
43. Palavecino EL, Riedel I, Berrios X, Bajaksouzian S, Johnson D, Kaplan E, Jacobs MR (2001) Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother 45: 339-341.
44. Lopardo HA, Hernandez C, Vidal P, Vazquez M, Rosaenz L, Rubinstein G, Smayevsky J, Tokumoto M, Fernandez Lausi A, Daher O, Kaufman S, Soriano SV, Brasili S, Bottiglieri M, Carranza MC (2004) Erythromycin-resistant Streptococcus pyogenes in Argentina. Medicina (B Aires) 64: 143-145.
45. Martinez S, Amoroso AM, Famiglietti A, de Mier C, Vay C, Gutkind GO (2004) Genetic and phenotypic characterization of resistance to macrolides in Streptococcus pyogenes from Argentina. Int J Antimicrob Agents 23: 95-98.
46. Rubinstein G, Amoroso AM, Bavdaz B, De Bunder S, Blazquez N, Gutkind GO (2005) Low macrolide resistance in Streptococcus pyogenes in Southern Argentina. Int J Antimicrob Agents 25: 450-452.
47. Ayer V, Tewodros W, Manoharan A, Skariah S, Luo F, Bessen DE (2007) Tetracycline resistance in group a streptococci: emergence on a global scale and influence on multiple-drug resistance. Antimicrob Agents Chemother 51: 1865-1868.